Traws Pharma
Price & Volume
Stats
See more52W Range | $0.97-$15 |
Market Cap | $7.9M |
Shares Short | 357,548 |
Financials
See moreRevenue (12 Mos) | $227,000 |
Revenue Growth (YoY) | 1.8% |
Gross Profit (12 Mos) | $227,000 |
Diluted EPS | -$27.20 |
News
See moreYahoo Finance • 25 days ago
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
Yahoo Finance • 3 months ago
Traws Pharma Announces Management Updates
Yahoo Finance • 3 months ago
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
Yahoo Finance • 3 months ago
Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
About
CEO | Dr. Iain D. Dukes DPHIL, M.A., Ph.D. |
Address | 12 Penns Trail, Newtown, PA, United States, 18940 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
